Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-119172
Filing Date
2024-11-14
Accepted
2024-11-14 16:53:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9092
  Complete submission text file 0001104659-24-119172.txt   10789
Mailing Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840 203-404-1172
Nantahala Capital Management, LLC (Filed by) CIK: 0001472322 (see all company filings)

EIN.: 201151760 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 2015 PEEL STREET 5TH FLOOR MONTREAL A8 H3A 1T8
Business Address 2015 PEEL STREET 5TH FLOOR MONTREAL A8 H3A 1T8 514-336-7800
Theratechnologies Inc. (Subject) CIK: 0001512717 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1130
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-86385 | Film No.: 241463813
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)